The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
VanA-Type Vancomycin-Resistant Staphylococcus aureus
Open accessAbstract
Since 2002, nine methicillin (meticillin)-resistant Staphylococcus aureus(MRSA) strains that are also resistant to vancomycin (VRSA) have been reported in the United States, including seven clinical isolates from Michigan. The strains harbor a plasmid-borne Tn 1546 element following conjugation from a glycopeptide-resistant Enterococcus strain. In the second step, Tn 1546 transposed to a resident plasmid in five strains; the acquired plasmid behaved as a suicide gene delivery vector, and the incoming DNA had been rescued by illegitimate recombination. Surprisingly, combination of a glycopeptide with a β-lactam has a strong synergistic effect against VRSA, both in vitro and in an animal model, despite resistance of the strains to both drug classes when administered separately. This results from the fact that the late peptidoglycan precursors ending in d-alanine-d-lactate (d-Ala-d-Lac) that are mainly synthesized in the presence of glycopeptide inducers are not substrates for PBP2′, which is the only transpeptidase that remains active in the presence of oxacillin. One VRSA strain is partially dependent on vancomycin for growth due to a mutation in the host d-Ala:d-Ala ligase, thus having to rely on the inducible resistance pathway for cell wall synthesis. Competition growth experiments in the absence of inducer between the MRSA recipient and isogenic VRSA transconjugant revealed a disadvantage for the transconjugant, accounting, in part, for the low level of dissemination of the VRSA clinical isolates. The association of multiple molecular and environmental factors has been implicated in the regional emergence of VRSA in Michigan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,425
Self-citationMcDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,399
VANCOMYCIN-RESISTANT ENTEROCOCCI
Uttley, A. C., Collins, C. H., Naidoo, J., & George, R. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91037-9 · Cited by 1,226
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
Structure, biochemistry and mechanism of action of glycopeptide antibiotics
Reynolds, P. E. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967563 · Cited by 699
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Arthur, M., Molinas, C., Depardieu, F., & Courvalin, P. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.1.117-127.1993 · Cited by 603
Self-citationCell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus
Cui, L., Ma, X., Sato, K., Okuma, K., Tenover, F. C., Mamizuka, E. M., Gemmell, C. G., Kim, M.-N., Ploy, M.-C., El Solh, N., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.5-14.2003 · Cited by 492
Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006
Sievert, D. M., Rudrik, J. T., Patel, J. B., McDonald, L. C., Wilkins, M. J., & Hageman, J. C. (2008) · Clinical Infectious Diseases · doi:10.1086/527392 · Cited by 483
Modes and Modulations of Antibiotic Resistance Gene Expression
Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., & Courvalin, P. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00015-06 · Cited by 427
Self-citationGlycopeptide resistance in enterococci
ARTHUR, M., REYNOLDS, P., & COURVALIN, P. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10063-9 · Cited by 414
Self-citationPinho, M. G., de Lencastre, H., & Tomasz, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191260798 · Cited by 384
Vancomycin-Resistant Staphylococcus aureus Isolate from a Patient in Pennsylvania
Tenover, F. C., Weigel, L. M., Appelbaum, P. C., McDougal, L. K., Chaitram, J., McAllister, S., Clark, N., Killgore, G., O'Hara, C. M., Jevitt, L., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.275-280.2004 · Cited by 370
Arthur, M., Molinas, C., & Courvalin, P. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.8.2582-2591.1992 · Cited by 338
Self-citationde Jonge, B. L., Chang, Y. S., Gage, D., & Tomasz, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49903-1 · Cited by 315
Waldron, D. E., & Lindsay, J. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.00418-06 · Cited by 300
Vancomycin-resistant Staphylococcus aureus
Howe, R. A., Bowker, K. E., Walsh, T. R., Feest, T. G., & MacGowan, A. P. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78597-4 · Cited by 274
Vancomycin-resistant Staphylococcus aureus--New York, 2004.
(2004) · PubMed · Cited by 252
Weigel, L. M., Donlan, R. M., Shin, D. H., Jensen, B., Clark, N. C., McDougal, L. K., Zhu, W., Musser, K. A., Thompson, J., Kohlerschmidt, D., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00576-06 · Cited by 237
Structure and Mechanism of Multifunctional Restriction Endonucleases
Yuan, R. (1981) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.50.070181.001441 · Cited by 198
Saha, B., Singh, A. K., Ghosh, A., & Bal, M. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47144-0 · Cited by 195
Arthur, M., Depardieu, F., Reynolds, P., & Courvalin, P. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.00617.x · Cited by 176
Self-citationFitness Cost of SCC mec and Methicillin Resistance Levels in Staphylococcus aureus
Ender, M., Holmes, N., Adhikari, R. P., & Berger‐Bächi, B. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2295-2297.2004 · Cited by 153
Reynolds, P. E., & Brown, D. F. J. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80036-3 · Cited by 148
Fitness Cost of VanA-Type Vancomycin Resistance in Methicillin-Resistant Staphylococcus aureus
Foucault, M.-L., Courvalin, P. M., & Grillot‐Courvalin, C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01702-08 · Cited by 137
Self-citationZhu, W., Clark, N. C., McDougal, L. K., Hageman, J., McDonald, L. C., & Patel, J. B. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00908-07 · Cited by 117
Aligholi, M., Emaneini, M., Jabalameli, F., Shahsavan, S., Dabiri, H., & Sedaght, H. (2008) · Medical Principles and Practice · doi:10.1159/000141513 · Cited by 112
Severin, A. I., Tabei, K., Tenover, F. C., Chung, M., Clarke, N., & Tomasz, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309593200 · Cited by 107
Baptista, M., Depardieu, F., Reynolds, P. E., Courvalin, P. M., & Arthur, M. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.4401812.x · Cited by 94
Self-citationVancomycin resistant Staphylococcus aureus in the United States
Woodford, N. (2002) · Weekly releases (1997–2007) · doi:10.2807/esw.06.28.01913-en · Cited by 91
Vancomycin-Dependent Enterococcus faecalis Clinical Isolates and Revertant Mutants
Van Bambeke, F., Chauvel, M., Reynolds, P. E., Fraimow, H. S., & Courvalin, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.41 · Cited by 88
Self-citationNoto, M. J., Fox, P. M., & Archer, G. L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01164-07 · Cited by 87
Clark, N. C., Weigel, L. M., Patel, J. B., & Tenover, F. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.470-472.2005 · Cited by 82
Staphylococcus aureus Strains That are Hypersusceptible to Resistance Gene Transfer from Enterococci
Sung, J. M.-L., & Lindsay, J. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01442-06 · Cited by 77
Périchon, B., & Courvalin, P. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00410-06 · Cited by 66
Self-citationAn Outbreak of Vancomycin-Dependent Enterococcus faecium in a Bone Marrow Transplant Unit
Kirkpatrick, B. D., Harrington, S. M., Smith, D. R., Marcellus, D. C., Miller, C., Dick, J. D., Karanfil, L. V., & Perl, T. M. (1999) · Clinical Infectious Diseases · doi:10.1086/313456 · Cited by 63
Fox, P. M., Lampen, R. J., Stumpf, K. S., Archer, G. L., & Climo, M. W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00232-06 · Cited by 58
Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy
Dever, L. L., Smith, S. M., Handwerger, S., & Eng, R. H. K. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.10.2770-2773.1995 · Cited by 56
Severin, A. I., Wu, S. W., Tabei, K., & Tomasz, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4566-4573.2004 · Cited by 51
Périchon, B., & Courvalin, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4281-4285.2004 · Cited by 44
Self-citationVancomycin-dependent Enterococcus faecalis
Farrag, N., Eltringham, I. J., & Liddy, H. (1996) · The Lancet · doi:10.1016/s0140-6736(96)24049-8 · Cited by 37
Gholizadeh, Y., Prévost, M., Françoise Van Bambeke, A., Casadewall, B., Tulkens, P. M., & Courvalin, P. M. (2001) · Protein Science · doi:10.1110/ps.39101 · Cited by 30
Self-citationSifaoui, F., & Gutmann, L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1409 · Cited by 30
UPDATE ON VANCOMYCIN RESISTANCE
Périchon, B., & Courvalin, P. M. (2000) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2000.tb11895.x · Cited by 22
Self-citation
Cited by
Mobile Genetic Elements Associated with Antimicrobial Resistance
Partridge, S. R., Kwong, S. M., Firth, N., & Jensen, S. O. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00088-17 · Cited by 2,751
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Huh, A. J., & Kwon, Y. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.002 · Cited by 1,864
Nanotechnology as a therapeutic tool to combat microbial resistance
Pelgrift, R. Y., & Friedman, A. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.011 · Cited by 1,432
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Metadata
- Authors
- Périchon, B., & Courvalin, P.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2009-11
- Volume
- 53
- Issue
- 11
- Pages
- 4580-4587
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2111691760
- Cited by
- 334
- References
- 44
- FWCI
- 17.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.